Resistencia a la insulina: la señal de alarma de la prediabetes

Insulin resistance is a condition where cells become less responsive to insulin's signal to absorb glucose from the blood. The pancreas compensates by producing more insulin, creating a cascade of metabolic problems:

• The vicious cycle: Insulin resistance → elevated insulin → increased fat storage (especially visceral) → more inflammation → worsening insulin resistance
• Early detection window: Insulin resistance develops 10-15 years before HbA1c becomes abnormal. Standard blood sugar tests (fasting glucose, HbA1c) are normal during this phase because the pancreas is working overtime to compensate.
• Prevalence: NHANES data suggests 40% of US adults aged 18-44 have some degree of insulin resistance, making it the most common metabolic dysfunction.

Conditions driven or worsened by insulin resistance:

• Type 2 diabetes (end-stage insulin resistance)
• PCOS (70% of PCOS patients are insulin resistant)
• Non-alcoholic fatty liver disease
• Cardiovascular disease
• Alzheimer's disease (sometimes called "type 3 diabetes")

Upload your metabolic panel to WAYJET's Medical Report Analyzer — include fasting insulin if available for HOMA-IR calculation.

Standard diabetes screening tests often miss insulin resistance because blood sugar remains normal until late in the process. More sensitive tests include:

• Fasting insulin: The most accessible test. Normal: 2-6 mIU/L. Borderline: 6-10 mIU/L. Elevated: above 10 mIU/L. Many labs report "normal" up to 25 mIU/L, but most endocrinologists consider values above 10 as concerning.
• HOMA-IR (Homeostatic Model Assessment): Calculated as (fasting glucose × fasting insulin) / 405. Normal: below 1.0. Concerning: 1.0-2.0. Insulin resistant: above 2.0.
• Triglyceride-to-HDL ratio: A simple proxy from standard lipid panels. Ratio above 3.0 strongly suggests insulin resistance (sensitivity 64%, specificity 68%). Ideal is below 2.0.
• Waist circumference: Above 40 inches (men) or 35 inches (women) is a strong clinical indicator.

Clinical signs of insulin resistance (often visible before blood tests turn abnormal):

• Acanthosis nigricans (dark, velvety patches on neck, armpits, groin)
• Skin tags (multiple)
• Central obesity (apple-shaped body)
• Difficulty losing weight despite calorie restriction
• Carbohydrate cravings, especially afternoon energy crashes

The encouraging news: insulin resistance is highly reversible with lifestyle intervention. Key evidence-based strategies:

• Exercise: The single most effective intervention. A single bout of moderate exercise improves insulin sensitivity for 24-48 hours. Both aerobic and resistance training are effective — resistance training may be superior for long-term insulin sensitivity improvement. Target: 150+ minutes moderate or 75+ minutes vigorous exercise weekly.
• Weight loss: Even 5-7% body weight loss significantly improves insulin sensitivity. Visceral fat loss is particularly impactful.
• Dietary changes: Reduce refined carbohydrates, increase fiber (30+ g/day), prioritize protein and healthy fats. A low-glycemic-index diet reduces insulin demand after meals. The Mediterranean diet has the strongest evidence for insulin resistance improvement.
• Sleep: Just 4 nights of sleep restriction (4.5 hours) reduces insulin sensitivity by 30%. Prioritize 7-9 hours of quality sleep.
• Supplements with evidence: Berberine (500mg 2-3x daily), magnesium (300-400mg daily), chromium (200-1,000 mcg daily), and omega-3s (2-4g EPA+DHA daily) all have meta-analyses supporting modest insulin sensitivity improvements.

Medication consideration: Metformin (500-2,000mg daily) is the most established pharmaceutical option for insulin resistance, particularly when lifestyle modifications alone are insufficient.